- Norwood Systems (NOR) has received a further $170,000 contract for software development services from Avicena Systems for the Avicena Sentinel pathogen screening instrument, Automated Lamp Testing System (ALTS)
- Under the agreement, Norwood will continue to develop and enhance the software functionality of ALTS, which allows the instrument to deliver up to 100,000 results daily
- Last year, the company secured a $100,000 contract with Avicena to develop the “operational prototype” requirements of the ALTS
- On the market this morning, Norwood is up 25 per cent and trading at 2 cents per share
Norwood Systems (NOR) has received a further $170,000 contract for software development services from Perth-based Avicena Systems.
The contract is for the Avicena Sentinel pathogen screening instrument, Automated Lamp Testing System (ALTS).
Under the agreement, Norwood will further develop and enhance the software functionality of ALTS, which allows the instrument to deliver up to 100,000 results daily.
Last year, the company announced it had secured a $100,000 contract with Avicena to develop the “operational prototype” requirements of the ALTS.
“Completion of the initial contract and the award of this contract illustrates that Norwood and Avicena can partner to successfully deliver innovative solutions which benefit the broader community,” CEO and Founder Paul Ostergaard said.
“Norwood is pleased to be able to contribute to the global effort against the pandemic. The continued evolution of the ALTS work has the potential to unlock further high-value opportunities for Norwood in this market segment,” he added.
ALTS offers low-cost genetic or viral screening services for population-scale health initiatives.
On the market this morning, Norwood is up 25 per cent and trading at 2 cents per share at 11:19 am AEST.